Xiaopeng Tong
Impact in
- Nephrology top 10%
- Acute Kidney Injury Research
-
- Sphingolipid Metabolism and Signaling
- Lipid Membrane Structure and Behavior
- Angiogenesis and VEGF in Cancer
Papers in
-
- Sphingolipid Metabolism and Signaling 3
- Lipid Membrane Structure and Behavior 3
-
- Sarcoma Diagnosis and Treatment 5
- Co-authors
- Yanzhang Li (4 shared papers)Shuxia Wang (4 shared papers)Hisanori Umehara (6 shared papers)Toshioki Sawaki (6 shared papers)Yasufumi Masaki (6 shared papers)Takafumi Kawanami (6 shared papers)Masao Tanaka (5 shared papers)Tsuneyo Mimori (2 shared papers)
- Journals
- International Immunology (3 papers)Bioorganic Chemistry (2 papers)American Journal of Physiology-Renal Physiology (2 papers)Journal of Orthopaedic Translation (2 papers)Cellular and Molecular Immunology (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Xiaopeng Tong
29 papers receiving 503 citations
Peers
Comparison fields: 5 of 95
- Nephrology 43
- Molecular Biology 239
- Immunology 71
- Cancer Research 45
- Rheumatology 43
Countries citing papers authored by Xiaopeng Tong
This map shows the geographic impact of Xiaopeng Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaopeng Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaopeng Tong more than expected).
Fields of papers citing papers by Xiaopeng Tong
This network shows the impact of papers produced by Xiaopeng Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaopeng Tong. The network helps show where Xiaopeng Tong may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaopeng Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 81 | |
| 2 | 2010 | 59 | |
| 3 | 2008 | 51 | |
| 4 | 2013 | 48 | |
| 5 | 2013 | 40 | |
| 6 | 2012 | 35 | |
| 7 | 2019 | 27 | |
| 8 | Cisplatin augments FAS-mediated apoptosis through lipid rafts. | 2010 | 23 |
| 9 | 2011 | 21 | |
| 10 | 2023 | 19 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 12 | |
| 13 | 2021 | 10 | |
| 14 | 2019 | 8 | |
| 15 | 2022 | 8 | |
| 16 | Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis. | 2010 | 8 |
| 17 | 2022 | 8 | |
| 18 | 2014 | 6 | |
| 19 | 2007 | 6 | |
| 20 | 2023 | 4 |
About Xiaopeng Tong
Xiaopeng Tong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Immunology and Rheumatology, having authored 32 papers that have together received 503 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (5 papers), Bone Tumor Diagnosis and Treatments (4 papers), Immune Cell Function and Interaction (3 papers), Sphingolipid Metabolism and Signaling (3 papers), Lymphatic System and Diseases (3 papers), Lipid Membrane Structure and Behavior (3 papers), Animal Virus Infections Studies (2 papers) and Shoulder Injury and Treatment (2 papers). The work is most often cited by research in Nephrology (43 citations), Molecular Biology (239 citations), Immunology (71 citations), Cancer Research (45 citations) and Rheumatology (43 citations). Xiaopeng Tong has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Yanzhang Li, Shuxia Wang, Hisanori Umehara, Toshioki Sawaki, Yasufumi Masaki, Takafumi Kawanami, Masao Tanaka, Tsuneyo Mimori, Tomoyuki Sakai and Jinjing Zhang. Their work appears in journals such as International Immunology, Bioorganic Chemistry, American Journal of Physiology-Renal Physiology, Journal of Orthopaedic Translation and Cellular and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.